Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study

Clinical trial NCT07620574 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07620574
Sponsor: Exelixis
Status: ENROLLING_BY_INVITATION
Phase: Phase 3
Study type: INTERVENTIONAL

Cancer Renal Cell Carcinoma (RCC)Pancreatic Neuroendocrine Tumors (pNET)Extra-Pancreatic NET (epNET)Hepatocellular Carcinoma (HCC)Differentiated Thyroid Cancer (DTC)Non-Clear Cell Renal Cell Carcinoma (nccRCC)Colorectal Cancer Prostate Cancer

Start date: 2026-07-30
Primary completion: 2030-05-31
Enrollment: 5000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.